|
1
|
Hackbarth CJ, Chen DZ, Lewis JG, et al:
N-alkyl urea hydroxamic acids as a new class of peptide deformylase
inhibitors with antibacterial activity. Antimicrob Agents
Chemother. 46:2752–2764. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang J, Di F, He R, et al: Efffect of
addition of low-dose rosiglitazone to sulphonylurea therapy on
glycemic control in type 2 diabetic patients. Chin Med J (Engl).
116:785–787. 2003.PubMed/NCBI
|
|
3
|
Cook JW, Sterman DH, Singhal S, Smythe WR
and Kaiser LR: Suramin inhibits the growth of malignant
mesothelioma in vitro, and in vivo, in murine flank and
intraperitoneal models. Lung Cancer. 42:263–274. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Easmon J, Purstinger G, Heinisch G, et al:
Synthesis, cytotoxicity, and antitumor activity of copper(II) and
iron(II) complexes of (4)N-azabicyclo[3.2.2]nonane
thiosemicarbazones derived from acyl diazines. J Med Chem.
44:2164–2171. 2001.PubMed/NCBI
|
|
5
|
Fujita F, Fujita M, Inaba H, Sugimoto T,
Okuyama Y and Taguchi T: Combination chemotherapy of HO-221, a
derivative of benzoylphenylurea with various anticancer agents
against human cancer xenografts in nude mice. Gan To Kagaku Ryoho.
18:2263–2270. 1991.PubMed/NCBI
|
|
6
|
Gnewuch CT and Sosnovsky G: A critical
appraisal of the evolution of N-nitrosoureas as anticancer drugs.
Chem Rev. 97:829–1014. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang JD, Denner L, Ling YH, et al: Double
blockade of cell cycle at g(1)-s transition and m phase by
3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand.
Cancer Res. 62:6080–6088. 2002.PubMed/NCBI
|
|
8
|
Jiang JD, Roboz J, Weisz I, et al:
Synthesis, cancericidal and antimicrotubule activities of
3-(haloacetamido)-benzoylureas. Anticancer Drug Des. 13:735–747.
1998.PubMed/NCBI
|
|
9
|
Okada H, Koyanagi T and Yamada N:
Synthesis and antitumor activities of prodrugs of
benzoylphenylureas. Chem Pharm Bull (Tokyo). 42:57–61. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Olaharski AJ, Mondrala ST and Eastmond DA:
Chromosomal malsegregation and micronucleus induction in vitro by
the DNA topoisomerase II inhibitor fisetin. Mutat Res. 582:79–86.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singh SK, Ruchelman AL, Li TK, Liu A, Liu
LF and LaVoie EJ: Nitro and amino substitution in the D-ring of
5-(2-dimethyl-aminoethyl)-2,3-methylenedioxy-5H-dibenzo[c,h][1,6]naph-thyridin-6-ones:
effect on topoisomerase-I targeting activity and cytotoxicity. J
Med Chem. 46:2254–2257. 2003.PubMed/NCBI
|
|
12
|
Toth JE, Grindey GB, Ehlhardt WJ, et al:
Sulfonimidamide analogs of oncolytic sulfonylureas. J Med Chem.
40:1018–1025. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao P, Huang XF, Ding H, et al: Synthesis
and cytotoxic evaluation of substituted urea derivatives as
inhibitors of human-leukemia K562 cells. Chem Biodivers. 4:881–886.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Si-Tu ZQ and Wu JZ: Cell Culture. 2nd
edition. World Publishing Corporation; Xi’an: pp. 200–201. 2007
|
|
15
|
Bliss C: The comparison of
dosage-mortality data. Ann Appl Biol. 22:307–333. 1935. View Article : Google Scholar
|
|
16
|
Tian Z, Si J, Chang Q, et al: Antitumor
activity and mechanisms of action of total glycosides from aerial
part of Cimicifuga dahurica targeted against hepatoma. BMC
Cancer. 7:2372007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Long L and Li Q: The effect of alkaloid
from Oxytropis ochrocephala on growth inhibition and
expression of PCNA and p53 in mice bearing H22 hepatocellular
carcinoma. Yakugaku Zasshi. 125:665–670. 2005.PubMed/NCBI
|
|
18
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hirohashi S, Shimosato Y, Kameya T, et al:
Production of alpha-fetoprotein and normal serum proteins by
xenotransplanted human hepatomas in relation to their growth and
morphology. Cancer Res. 39:1819–1828. 1979.PubMed/NCBI
|
|
20
|
Srivastava JK and Gupta S:
Tocotrienol-rich fraction of palm oil induces cell cycle arrest and
apoptosis selectively in human prostate cancer cells. Biochem
Biophys Res Commun. 346:447–453. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stolarska M, Mlynarski W,
Zalewska-Szewczyk B and Bodalski J: Cytoprotective effect of
amifostine in the treatment of childhood neoplastic diseases – a
clinical study including the pharmacoeconomic analysis. Pharmacol
Rep. 58:30–34. 2006.PubMed/NCBI
|
